DGHI Prepares for Annual CUGH Conference

Duke Global Health Institute will be well represented at The Consortium of Universities for Global Health’s Annual Conference slated for Feb. 20-23. In Atlanta, Ga., the event will focus on “Innovating and Implementing in Global Health for a Sustainable Future.”

Faculty and staff from DGHI will participate in panels and sessions focused on a range of topics. That includes assessing the feasibility all countries can halve their probability of premature death by 2050, stemming from the Lancet Commission on Investing in Health. DGHI expanded on this report, which was released last fall, as six of the study’s authors are from the institute and the Duke Center for Policy Impact in Global Health (CPIGH).

Joining faculty and staff this year are global health graduate and undergraduate students as some will present their current research work. See below for this year’s attendees from DGHI and click here for the full CUGH conference schedule:

Panels

• Gavin Yamey, M.D., director of CPIGH, will moderate, “Global Health 2050: Insights from the 3rd Report of the Lancet Commission on Investing in Health.”
   
• Wenhui Mao, Ph.D., assistant director of programs for the Duke Global Health Innovation Center, will serve as a panelist on the abovementioned panel.
   
• Karla Rascon-Garcia, Ph.D., a postdoctoral associate, will be a panelist on “Training the Next Generation of Global Health Researchers: the NIH-Fogarty Global Health Program for Fellows and Scholars/Launching Future Leaders in Global Health Research Training Program (LAUNCH).”

Sessions

• Mao will co-host a session on “Harnessing Technology and AI for Collaborative Breakthroughs in Global Health.”

Poster and Oral Abstract Sessions

• Maddie Kitts, a 2nd-year Master of Science in Global Health student, will present on “Facilitators and Barriers to Scale-Up of Universal Newborn Screening for Sickle Cell Disease in Kalangala, Uganda.”
   
• Kiara Ekeigwe, a 4+1 MS-GH student and research analyst with CPIGH, will present on a costing analysis on three countries’ COVID-19 test and treatment programs as part of a larger project by the COVID Treatment QuickStart Consortium.